Varun Chaudhary
Dr. Chaudhary is Professor of Surgery and Chief of Ophthalmology at McMaster University. He is the Chair for the Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.). He is the current President for the Canadian Retina Society.
He is passionate about evidence generation in the field of retina. He has over 80 publications and as Principal Investigator he has secured over $40 million in research grant funding. He serves on multiple clinical and medical advisory boards and global steering committees for retina endeavors spanning from basic science research to multi-national clinical trials in the field of retina.
He is the Editor-in-Chief for the Canadian Journal of Ophthalmology and Section Editor for Medical Retina for Eye.
He has been awarded multiple Education, Achievement and Research Awards along with the Honor and Senior Honor Award by the American Society of Retinal Specialists and the Award for Excellence in Ophthalmic Research by the Canadian Ophthalmological Society.
Financial disclosure: Dr. Chaudhary has/had an affiliation (financial or otherwise) with a commercial organization:
- Bayer
- Boehringer Ingelheim
- Novartis
- Roche
Sessions in which Varun Chaudhary participates
الأحد 3 يونيو, 2018
الجمعة 14 يونيو, 2019
الأحد 16 يونيو, 2019
الجمعة 26 يونيو, 2020
السّبت 27 يونيو, 2020
السّبت 26 يونيو, 2021
Learning ObjectivesAt the end of this session, participants will be able to:Describe new therapeutic options for the treatment of neovascular macular degenerationIntegrate key aspects of the evaluation of posterior uveitisOptimize management of submacular hemorrhageCanMEDS Roles: Medical Expert, Scholar
Authors: Varun Chaudhary, Michael Larsen, Nicole Eter, Clare Bailey, Sebastian Wolf, Thomas Schmelter, Helmut Allmeier, Jean-François Korobelnik. Disclosure Block: V. Chaudhary: Membership on advisory boards or speakers’ bureaus; Name of for-profit or not-for-profit organization(s); Alcon Laboratories, Bayer Healthcare, Novartis Pharma AG. Membership on advisory boards or speakers’ bureaus; Description of relationship(s); Served as a Scie...
الأحد 27 يونيو, 2021
Authors: Varun Chaudhary, Frank G. Holz, Edoardo Midena, Eric Souied, Sebastian Wolf, George Lambrou, Tobias Machewitz, Paul Mitchell. Disclosure Block: V. Chaudhary: Membership on advisory boards or speakers’ bureaus; Name of for-profit or not-for-profit organization(s); Alcon Laboratories, Bayer Healthcare, Novartis Pharma AG. Membership on advisory boards or speakers’ bureaus; Description of relationship(s); Served as a Scientific Advisor, ...
السّبت 11 يونيو, 2022
Learning ObjectivesAt the end of this session, participants will be able to:Manage macular edema secondary to retinal vein occlusionDescribe management of peripapillary choroidal melanomasIntegrate new concepts in retinal detachment managementCanMEDS Roles: Medical Expert, Scholar
Authors: Varun Chaudhary, Anat Loewenstein, Veeral Sheth, Karl Csaky, Rose Edmonds, Michael Chang, Jeffrey R. Willis, Zdenka Haskova, Peter D. Westenskow. Author Disclosure Block: V. Chaudhary: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Novartis, Bayer. Any direct financial payments including receipt of honoraria; Description of relationship(s); Speaker fees. Membership on ad...
Authors: Varun Chaudhary, Jean-François Korobelnik, Paul Mitchell, Se Woong Kang, Ramin Tadayoni, Helmut Allmeier, JinKyung Lee, Tobias Machewitz, Kristian T. Johnson, Clare Bailey. Author Disclosure Block: V. Chaudhary: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Novartis, Bayer. Any direct financial payments including receipt of honoraria; Description of relationship(s); Spe...
الأحد 12 يونيو, 2022
LEARNING OBJECTIVESAt the end of this symposium, participants will be able to:Identify the critical unmet needs in neovascular AMD and DME managementDemonstrate a comprehensive understanding of new therapeutic agents and their mechanism of action in nAMD and DME managementExamine how to incorporate new therapeutic options into current management strategies for patients with nAMD and DMEApply new insights from multi-modal imagin...
Learning ObjectivesAt the end of this session, participants will be able to:Recognize features of optic neuritis requiring prompt investigation and more aggressive managementDescribe the challenges of and barriers to delivering eye care to indigent populationsRecognize features of optic neuritis requiring prompt investigation and more aggressive management
السّبت 17 يونيو, 2023
*Breakfast to be served from 6:00am* Learning Objectives: At the end of this session, participants will be able to: Outline the role of the Tie-2/ang pathway in DR and nAMDand how it may impact patient outcomesIdentify the most important biomarkerson structural OCT that can help predict treatmentresponse in DME and nAMDDiscuss r...
